OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Roxadustat, a HIF-PHD inhibitor with exploitable potential on diabetes-related complications
Tingting Fang, Congcong Ma, Zhanming Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 13
Tingting Fang, Congcong Ma, Zhanming Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 13
Showing 13 citing articles:
Hydrogels loaded with MSC‐derived small extracellular vesicles: A novel cell‐free tissue engineering system for diabetic wound management
Weicheng Zhong, Hao Meng, Liqian Ma, et al.
View (2024) Vol. 5, Iss. 4
Open Access | Times Cited: 10
Weicheng Zhong, Hao Meng, Liqian Ma, et al.
View (2024) Vol. 5, Iss. 4
Open Access | Times Cited: 10
Metabolic reprogramming in septic acute kidney injury: pathogenesis and therapeutic implications
Caihong Liu, Wei Wei, Yongxiu Huang, et al.
Metabolism (2024) Vol. 158, pp. 155974-155974
Closed Access | Times Cited: 6
Caihong Liu, Wei Wei, Yongxiu Huang, et al.
Metabolism (2024) Vol. 158, pp. 155974-155974
Closed Access | Times Cited: 6
Salvianolic acid B ameliorates myocardial fibrosis in diabetic cardiomyopathy by deubiquitinating Smad7
Hong Luo, Lingyun Fu, Xueting Wang, et al.
Chinese Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 12
Hong Luo, Lingyun Fu, Xueting Wang, et al.
Chinese Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 12
Cardiovascular and renal safety outcomes of hypoxia-inducible factor prolyl-hydroxylase inhibitor roxadustat for anemia patients with chronic kidney disease: a systematic review and meta-analysis
Lei Tian, Mengdi Wang, Mengchao Liu, et al.
Renal Failure (2024) Vol. 46, Iss. 1
Open Access | Times Cited: 4
Lei Tian, Mengdi Wang, Mengchao Liu, et al.
Renal Failure (2024) Vol. 46, Iss. 1
Open Access | Times Cited: 4
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat Accelerates Wound Healing in a Mouse Hind limb Lymphedema Model
Kosuke Ishikawa, Yoshitada Hoshino, Masayuki Osawa, et al.
Advances in Wound Care (2025)
Closed Access
Kosuke Ishikawa, Yoshitada Hoshino, Masayuki Osawa, et al.
Advances in Wound Care (2025)
Closed Access
High glucose/ChREBP-induced Hif-1α transcriptional activation in CD4+ T cells reduces the risk of diabetic kidney disease by inhibiting the Th1 response
Shaoyong Zhuang, Nan Sun, Junwen Qu, et al.
Diabetologia (2025)
Open Access
Shaoyong Zhuang, Nan Sun, Junwen Qu, et al.
Diabetologia (2025)
Open Access
A smart drug delivery microgel system with phased intervention capabilities and dual physical state of use promotes healing of diabetic infected wounds
Fei Ma, Yuheng Liu, Yu Wang, et al.
Journal of Materials Chemistry B (2025)
Closed Access
Fei Ma, Yuheng Liu, Yu Wang, et al.
Journal of Materials Chemistry B (2025)
Closed Access
FG-4592 combined with PRP significantly accelerates the healing of refractory diabetic wounds by upregulating HIF-1α
Di Tang, Qiang Lin, Pei-Wen Li, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Di Tang, Qiang Lin, Pei-Wen Li, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Localized delivery of Roxadustat via cubosomes-based thermosensitive in-situ hydrogel enhances diabetic wound healing by stabilizing HIF-1α in rats
Mohamed Nasr, Ahmed Y. Kira, Sameh Saber
Journal of Drug Delivery Science and Technology (2024) Vol. 100, pp. 106127-106127
Closed Access | Times Cited: 3
Mohamed Nasr, Ahmed Y. Kira, Sameh Saber
Journal of Drug Delivery Science and Technology (2024) Vol. 100, pp. 106127-106127
Closed Access | Times Cited: 3
Activation of the hypoxia-inducible factor pathway by roxadustat improves glucose metabolism in human primary myotubes from men
Selina Mäkinen, Sreesha Sree, Tuulia Ala‐Nisula, et al.
Diabetologia (2024) Vol. 67, Iss. 9, pp. 1943-1954
Open Access | Times Cited: 2
Selina Mäkinen, Sreesha Sree, Tuulia Ala‐Nisula, et al.
Diabetologia (2024) Vol. 67, Iss. 9, pp. 1943-1954
Open Access | Times Cited: 2
Roles of Hypoxia-Inducible Factor-Prolyl Hydroxylases in Aging and Disease
Fedor Galkin, Fadi E. Pulous, Yanyun Fu, et al.
Ageing Research Reviews (2024) Vol. 102, pp. 102551-102551
Open Access | Times Cited: 1
Fedor Galkin, Fadi E. Pulous, Yanyun Fu, et al.
Ageing Research Reviews (2024) Vol. 102, pp. 102551-102551
Open Access | Times Cited: 1
Response to"Roxadustat: more than an erythropoietic agent?"
Weiwei Kong, Xiaoying Wu, Hongfeng Huang
Kidney International Reports (2024) Vol. 10, Iss. 1, pp. 276-276
Open Access
Weiwei Kong, Xiaoying Wu, Hongfeng Huang
Kidney International Reports (2024) Vol. 10, Iss. 1, pp. 276-276
Open Access
Cardiovascular and renal safety outcomes of Hypoxia-inducible factor Prolyl-Hydroxylase Inhibitor Roxadustat for Anemia patients with chronic kidney disease: a systematic review and meta-analysis
Lei Tian, Mengdi Wang, Mengchao Liu, et al.
Authorea (Authorea) (2023)
Open Access
Lei Tian, Mengdi Wang, Mengchao Liu, et al.
Authorea (Authorea) (2023)
Open Access
Salvianolic Acid B (Sal B) ameliorates myocardial fibrosis in diabetic cardiomyopathy through deubiquitinating Smad7
Hong Luo, Lingyun Fu, Xueting Wang, et al.
Research Square (Research Square) (2023)
Open Access
Hong Luo, Lingyun Fu, Xueting Wang, et al.
Research Square (Research Square) (2023)
Open Access
